During the past decade, Sírio Libanês conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sírio Libanês" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Janssen-Cilag Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sírio Libanês" are "Prostate Cancer" (1 trials), "Prostatic Neoplasms, Castration-Resistant" (1 trials) and "Recurrent/Metastatic Urothelial Cancers" (1 trials). Many other conditions were trialed in "Sírio Libanês" in a lesser frequency.

Most popular intervention types in "Sírio Libanês" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darolutamide" (1 trials) and "Testosterone Cypionate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sírio Libanês" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Sírio Libanês". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sírio Libanês, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sírio Libanês, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".